Spectrum Pharmaceuticals Stock News

Spectrum Pharmaceuticals, Inc. (SPPI) shares closed 0.8% lower than its previous 52 week low, giving the company a market cap of $208M. The stock is currently flat year-to-date, down 63.5% over the past 12 months, and down 73.5% over the past five years. This week, the Dow Jones Industrial Average fell 0.2%, and the S&P 500 fell 1.9%. Trading Activity Trading volume this week was 53.5% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.6. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -100.0% The company's stock price performance over the past 12 months lags the peer average by -2385.8% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

The stock price of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) fell by 11.19% in the most recent trading session. This is why it happened.

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Liquidia Appoints Pharma Industry Veteran Roger Jeffs As CEO Liquidia Corporation (NASDAQ: LQDA) annou

(PR-inside.com) SAN DIEGO, CA / ACCESSWIRE / December 22, 2021 / Shareholder rights law firm Robbins LLP is investigating Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) to determine whether certain Spectrum officers and directors violated the Securities Exchange Act of 1934 and breached fiduciary duties to shareholders. Spectrum is a biopharmaceutical company that develops and commercializes oncology and hematology drug products. One product the Company has under development is ROLONTIS (eflapegrastim), a novel long-lasting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia. If you would like more information about Spectrum Pharmaceuticals, Inc.''s misconduct, click here. Spectrum Pharmaceuticals, Inc. (SPPI) May Have Materially Misrepresented the Likelihood ROLONTIS Would be ..

Investors need to pay close attention to Spectrum Pharmaceuticals (SPPI) stock based on the movements in the options market lately.

Investors need to pay close attention to Spectrum Pharmaceuticals (SPPI) stock based on the movements in the options market lately.

Looking for potential short squeeze penny stocks? Start by looking at short interest The post Best Penny Stocks To Buy Now? 10 Short Squeeze Stocks To Watch appeared first on Penny Stocks to Buy, Pick

Looking for potential short squeeze penny stocks? Start by looking at short interest The post Best Penny Stocks To Buy Now?

The heavy selling pressure might have exhausted for Spectrum Pharma (SPPI) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street ana

In the last trading session, 3.54 million Spectrum Pharmaceuticals Inc. (NASDAQ:SPPI) shares changed hands as the companys beta touched 1.90. With the companys per share price at $1.37 changed hands at -$0.21 or -13.29% during last session, the market valuation stood at $259.09M. SPPIs last price was a discount, traded about -282.48% off its 52-week SPPI Stock: More Upside For Spectrum Pharmaceuticals Inc. (NASDAQ: SPPI)? Read More »

The heavy selling pressure might have exhausted for Spectrum Pharma (SPPI) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street ana

The stock price of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) increased by over 2% pre-market today. This is why it happened.

Spectrum Pharmaceuticals Inc. (NASDAQ:SPPI) concluded the trading at $1.58 on Thursday, December 02 with a fall of -5.95% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $1.68 and 5Y monthly beta was reading 2.27 with its price kept floating in the … Spectrum Pharmaceuticals Inc. (SPPI) Is Waiting On The Launchpad To Make A Splash. Read More »

Top penny stocks traders decided to buy today but are they worth the risk? The post 4 Top Penny Stocks To Buy For Under $5 appeared first on Penny Stocks to Buy, Picks, News and Information | PennySto